Abstract: Monitoring system and method for use with diabetic treatment management. The system includes: a communication interface configured to permit access to stored raw log data, obtained over a certain time, being indicative of glucose measurements, meals consumed and insulin delivery; and a control unit including an unsupervised learning controller configured to receive and process said raw log data and determine at least one global insulin pump setting of basal rate, correction factor, carbohydrate ratio and insulin activity curve parameters. The system may include a processing unit including a first processor for processing measured data indicative of blood glucose level and generating first processed data, a second processor including at least one fuzzy logic module which receives input parameters corresponding to the measured data, the first processed data and a reference data, and processes the data to produce a qualitative output parameter to determine whether any treatment parameter should be modified.
Type:
Application
Filed:
March 29, 2012
Publication date:
September 27, 2012
Applicant:
MOR RESEARCH APPLICATIONS LTD.
Inventors:
Eran ATLAS, Revital NIMRI, Shahar MILLER, Eli Aviram GRUNBERG, Moshe PHILLIP
Abstract: Antisense oligonucleotides against cPLA2 are provided, which are capable of inhibiting cPLA2 expression as well as superoxide production, especially in phagocytes. These antisense oligonucleotides are powerful agents for the treatment of inflammatory conditions, in particular arthritis, as well as in neurodegenerative diseases. The antisense oligonucleotides or compositions comprising the same may be used in methods of treatment of such diseases.
Type:
Grant
Filed:
April 17, 2005
Date of Patent:
August 14, 2012
Assignees:
Mor Research Applications Ltd., Ben Gurion University of the Negev Research and Development Authority
Abstract: Specifically, a dry corn fractionation system which operates to produce an endosperm fraction which can be concurrently of greater purity at greater yield than obtainable from corn milling or dry corn milling processes.
Type:
Grant
Filed:
December 12, 2007
Date of Patent:
July 24, 2012
Assignee:
MOR Technology, LLC
Inventors:
Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston, Rodger T. Marentis
Abstract: A method of analyzing a stream of imaging data is disclosed. The method comprises: for each picture-element of the data, associating a vector of features indicative of temporal intensity variation relative to baseline intensity, thereby providing a plurality of vectors. The method further comprises clustering the picture-elements according to the vectors, thereby providing a plurality of clusters, and identifying different compartments in the vasculature based on the clusters.
Type:
Application
Filed:
September 1, 2009
Publication date:
June 21, 2012
Applicants:
Mor Research Applications Ltd, Ben Gurion University Of The Negev Research and Development Authority
Inventors:
Alon Friedman, Yoash Chassidim, Ofer Psager, Ilan Shelef
Abstract: The present invention is directed to the field of cancer diagnosis, specifically to the diagnosis of bladder cancer (BC) and prostate cancer (CaP). More specifically, the invention provides simple, non-invasive urinary tests characterized by high sensitivity and specificity, wherein urinary levels of heat shock proteins and anti-inflammatory cytokines are used as biomarkers.
Type:
Application
Filed:
August 3, 2010
Publication date:
June 14, 2012
Applicants:
MOR - RESEARCH APPLICATIONS LTD., YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventors:
Irun R. Cohen, Meirav Pevsner-Fischer, David Margel, Jack Baniel, Ofer Yossepowitch
Abstract: Generally, a method of pressure regulated supercritical fluid fractionation of oil seed extraction materials which can be utilized to refine oil seed extraction material established in an amount of supercritical fluid. Specifically, a method of pressure regulated supercritical fluid fractionation of corn germ extraction material to produce a refined corn oil extraction material.
Abstract: A medical diagnosis decision support system for assisting a health professional to diagnose a medical condition. The system is first provided with an anchor condition that can be a symptom, a sign, a laboratory test result, or an imaging test results or any combination thereof The system then guides users in a series of predetermined phases regarding abstract or concrete diagnosis groups that should be considered and appropriate data that should be collected during the clinical investigation process. The system suggests history and physical examination clinical data items, laboratory, and imaging tests that should be collected in order to differentiate among alternative diagnoses. In each phase, possible diagnoses are listed and ranked.
Type:
Application
Filed:
April 14, 2010
Publication date:
October 20, 2011
Applicants:
CARMEL-HAIFA UNIVERSITY ECONOMIC CORP. LTD., MOR RESEARCH APPLICATIONS LTD.
Abstract: The present invention provides to a humanized monoclonal antibody having immunostimulatory effects. This antibody binds specifically to B lymphoblastoid cells, induces proliferation and activation of peripheral blood lymphocytes, particularly T cells, and is capable of eliciting an anti-tumor effect upon administration to subjects suffering from an immune deficiency.
Abstract: The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
Type:
Application
Filed:
November 5, 2008
Publication date:
January 20, 2011
Applicant:
MOR RESEARCH APPLICATIONS LTD
Inventors:
Shmuel Ariad, Jacob Gopas, Daniel Benharroch, Irina Lazarev
Abstract: This invention is directed, inter alia, to methods and kits for rapid, easy and cost-effective methods of all free nucleic acid quantification in inter alia, biological fluid samples.
Abstract: An arrow tip and target system, including a tip having a removable marking material integral with an end surface of the tip, and a target. An arrow for marking a target, including a shaft and a tip fixedly mounted thereon, the tip including a removable marking material integral with an end surface of the tip. A tip for attachment to an arrow, including a removable marking material integral with an end surface of the tip. A kit including a target, arrow tips, marking material, games, and rules for the games. A method of playing a game with an arrow tip and target system by attaching a tip including removable marking material to an arrow, launching the arrow towards a target according to the game being played, contacting the tip with the target, and removably marking the target.
Abstract: Methods and devices for augmenting an atrioventricular valve leaflet is disclosed. A method according to an exemplary embodiment includes piercing a leaflet of the valve to at least a portion of the leaflet's thickness to form a pierced section; and extending the leaflet using said pierced section. A device according to an exemplary embodiment of the invention includes a catheter comprising: a longitudinal tube having a lumen; and a cutting element extendable from the lumen. The cutting element is adapted for forming a limited cut in an atrioventricular valve. A device according to another exemplary embodiment of the invention includes a catheter comprising a longitudinal tube having a lumen; a cutting element extendable from the lumen and adapted for forming a cut in a leaflet of an atrioventricular valve; and a frame, configured to attach to the leaflet and stay attached to the leaflet when the heart beats.
Type:
Application
Filed:
June 4, 2008
Publication date:
August 12, 2010
Applicants:
Mor Research Applications Ltd., Nisan ZEF
Abstract: The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.
Abstract: Methods and compositions for preventing or reducing weight gain associated with drug treatment, which utilize an H1 agonist such as betahistine, betahistine metabolite or a betahistine salt are disclosed.
Abstract: A method of reducing weight gain associated with olanzapine treatment in a human subject, by orally administering to an olanzapine-treated subject betahistine or a salt thereof, is disclosed.
Abstract: Pharmaceutical compositions are disclosed comprising betahistine, or a salt thereof, and olanzapine in amounts effective to reduce the weight gain associated with olanzapine administration.
Abstract: A hitch coupling assembly attaching a trailer to a towing vehicle. The towing vehicle including a hitch plate that has an upper surface and an open end for receiving a king pin. The coupling assembly has an arm with opposite ends. A skid plate is attached to one end of the arm and the skid plate has a perimeter defined by sides. The king pin extends from a surface of the skid plate. A journal pin is attached to the opposite end of the arm and is rotatable relative to the arm. The journal pin is optionally lockable or the arm relative to the hitch is optionally lockable.
Type:
Grant
Filed:
November 28, 2007
Date of Patent:
April 27, 2010
Assignee:
MOR/ryde International, Inc.
Inventors:
David E. Heitzmann, Jonathan D. Kauffman
Abstract: The invention concerns novel DNA and amino acid sequences of monoclonal antibodies (mAbs) raised against lymphoblastoid cells and peptides to which the mAbs bind to. The invention also concerns diagnostic assays using said antibodies or peptides for detecting individuals with a high probability of having a malignant disease and, at times, for detecting an individual having a specific malignant disease. The invention further concerns pharmaceutical compositions comprising the mAbs or peptides of the invention for use in the treatment of various malignant diseases as well as methods for the treatment of malignant diseases using the mAbs or peptides of the invention.
Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
Type:
Grant
Filed:
October 2, 2007
Date of Patent:
March 2, 2010
Assignees:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts, Mor Research Applications, Ltd.
Abstract: A method of reducing extracellular brain glutamate levels is provided. The method comprising administering to a subject in need thereof an agent capable of modulating stress hormone activity thereby reducing blood glutamate levels, thereby reducing extracellular brain glutamate levels.
Type:
Application
Filed:
March 8, 2007
Publication date:
December 10, 2009
Applicants:
Yeda Research And Development Co. Ltd. at the Weizmann Institute of Sceince, Mor Research Applications Ltd.
Inventors:
Vivian I. Teichberg, Alexander Zlotnik, Yoram Shapira